Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 pilot) trial

Journal of the American College of Cardiology

Volumn 36, Issue 5, 2000, Pages 1489-1496

  Herrmann, Howard C ^a   Moliterno, David J ^b   Ohman, E Magnus ^c   Stebbins, Amanda L ^c   Bode, Christopher ^d   Betriu, Amadeo ^e   Forycki, Florian ^f   Miklin, Jerry S ^g   Bachinsky, William B ^h   Lincoff, A Michael ^b   Califf, Robert M ^c   Topol, Eric J ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e HOSPITAL CLÍNIC   (Spain)

^f MARTIN LUTHER KRANKENHAUS   (Germany)

^g Exempla Lutheran Medical Center   (United States)

^h Harrisburg Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; RETEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CINEANGIOCARDIOGRAPHY; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECOMBINANT PROTEINS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0034332695     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00923-2     Document Type: Article

References (27)

1. Thrombolysis and mechanical intervention following myocardial infarction
2. Immediate vs. delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction
3. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction
4. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: No additional benefit from immediate percutaneous coronary angioplasty
5. SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction
6. Randomized trial of abciximab with and without low-dose reteplase for acute myocardial infarction
7. Thrombolysis In Myocardial Infarction (TIMI) trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase
8. TIMI frame count: A quantitative method of assessing coronary artery flow
9. Abciximab facilitates the rate and extent of thrombolysis - Results of the Thrombolysis In Myocardial Infarction (TIMI) 14 trial
10. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT Trial
11. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction
12. Randomized placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT)
13. Abciximab associated with primary angioplasty and stenting in acute myocardial infarction: The ADMIRAL study, 30-day final results
14. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial
15. Coronary angioplasty with or without stent implantation for acute myocardial infarction
16. Stenting and IIb/IIIa receptor blockade in acute myocardial infarction: An introduction to the CADILLAC trial
17. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction
18. A comparison of reteplase with alteplase for acute myocardial infarction
19. Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial)
20. Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction
21. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction
22. A comparison of immediate angioplasty with thrombolyric therapy for acute myocardial infarction
23. The GUSTO-IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction
24. Primary angioplasty compared with thrombolysis: New issues in the era of glycoprotein IIb/IIIa inhibition and intracoronary stenting
25. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
26. TIMI flow and surrogate endpoints: What you see is not always what you get
27. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA